18,166 recalls
II
Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Container, sterile, Nonpyrogenic, iso-osmoti…
CGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
II
CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-…
CGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
II
Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAX…
CGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
II
Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only…
CGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
II
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single D…
CGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
II
Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only, Sterile Nonpyr…
CGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
II
Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, St…
CGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
II
Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container…
CGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
II
MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Cor…
CGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
II
Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, Rx only, Sterile Non…
CGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
I
Lactated Ringer's Injection USP, 1000 mL EXCEL container, Rx only, L7500, B.
Presence of Particulate matter.
B Braun Medical Inc · Sep 2, 2026
II
Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bott…
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
Hikma Pharmaceuticals USA INC. · Sep 2, 2026
I
Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, L…
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Fresenius Kabi USA, LLC · Sep 2, 2026
II
Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto,…
Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
Apotex Corp. · Sep 2, 2026
II
Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd.
Presence of particulate matter: glass and stopper piece
Mallinckrodt Hospital Products Inc. · Sep 2, 2026
II
Zicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus, 20 Single-Use Swabs per carton, Zinc-Free…
CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing
Church & Dwight Co., Inc. · Sep 2, 2026
II
Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34…
Failed content uniformity specifications.
Lupin Pharmaceuticals Inc. · Sep 2, 2026
II
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc…
Subpotent Drug
Accord Healthcare, Inc. · Sep 2, 2026
II
Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-coun…
Subpotent Drug
Accord Healthcare, Inc. · Sep 2, 2026
II
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-c…
Subpotent Drug
Accord Healthcare, Inc. · Sep 2, 2026